July 4, 2024

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Ethiopia’s Major Economic Performance in 2016 EFY

ADDIS ABABA: During the 36th Regular Session of the House of People’s Representatives held today, Prime Minister Abiy Ahmed highlighted the major achievements of the fiscal year.

According to Ethiopian News Agency, the payment for debt service and d…

36th Regular Session of HPR Underway in Presence of PM Abiy

ADDIS ABABA: Ethiopia’s House of Peoples Representatives (HPR) is holding its 36th regular session in the presence of Prime Minister Abiy Ahmed. The Prime Minister will address questions from members of the House in addition to explaining the federal …

PM Abiy Responds to Questions from House Members

ADDIS ABABA: Prime Minister Abiy Ahmed is responding to questions put to him by members of the House of People’s Representatives (HPR) in connection with the just-ended performance report of the government. Earlier, members of parliament forwarded que…